Epithelial to mesenchymal transition and breast cancer

被引:232
|
作者
Tomaskovic-Crook, Eva [1 ]
Thompson, Erik W. [2 ,3 ]
Thiery, Jean Paul [1 ]
机构
[1] Inst Mol & Cell Biol, Singapore 138673, Singapore
[2] St Vincents Inst Med Res, Melbourne, Vic 3065, Australia
[3] Univ Melbourne, Dept Surg, St Vincents Hosp, Melbourne, Vic 3065, Australia
来源
BREAST CANCER RESEARCH | 2009年 / 11卷 / 06期
关键词
CIRCULATING TUMOR-CELLS; BONE-MARROW MICROMETASTASIS; BASAL-LIKE PHENOTYPE; GENE-EXPRESSION; STEM-CELL; MAMMARY-TUMORS; METASTATIC-DISEASE; CLINICAL-RELEVANCE; HISTOLOGICAL GRADE; PROGNOSTIC-FACTOR;
D O I
10.1186/bcr2416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial-mesenchymal plasticity in breast carcinoma encompasses the phenotypic spectrum whereby epithelial carcinoma cells within a primary tumor acquire mesenchymal features and re-epithelialize to form a cohesive secondary mass at a metastatic site. Such plasticity has implications in progression of breast carcinoma to metastasis, and will likely influence response to therapy. The transcriptional and epigenetic regulation of molecular and cellular processes that underlie breast cancer and result in characteristic changes in cell behavior can be monitored using an increasing array of marker proteins. Amongst these markers exists the potential for emergent prognostic, predictive and therapeutic targeting.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Does Epithelial-Mesenchymal Transition Underlie Breast Cancer Metastases?
    Nassar, H.
    Hicks, J.
    DeMarzo, A.
    Halushka, M.
    Sukumar, S.
    Argani, P.
    MODERN PATHOLOGY, 2009, 22 : 341A - 341A
  • [22] Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women
    Lakhtakia, Ritu
    Aljarrah, Adil
    Furrukh, Muhammad
    Ganguly, Shyam S.
    CANCER MICROENVIRONMENT, 2017, 10 (1-3) : 25 - 37
  • [23] Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells
    Kim, Hyun A.
    Lee, Joomin
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [24] The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer
    Voutsadakis, Ioannis A.
    BREAST CANCER-TARGETS AND THERAPY, 2015, 7 : 303 - 319
  • [25] Exploring the Metabolic Vulnerabilities of Epithelial-Mesenchymal Transition in Breast Cancer
    Sun, Xiangyu
    Wang, Mozhi
    Wang, Mengshen
    Yao, Litong
    Li, Xinyan
    Dong, Haoran
    Li, Meng
    Li, Xiang
    Liu, Xing
    Xu, Yingying
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [26] Study of diphenylamine analogs as inducers of mesenchymal to epithelial transition in breast cancer
    Bhatt, A. B.
    Wright, T. D.
    Anna, K.
    Gupta, M.
    Chakrabarty, S.
    Flaherty, P. T.
    Hoang, V.
    Burow, M.
    Cavanaugh, J. E.
    CANCER RESEARCH, 2019, 79 (04)
  • [27] Partial Mesenchymal to Epithelial Reverting Transition in Breast and Prostate Cancer Metastases
    Chao, Yvonne
    Wu, Qian
    Acquafondata, Marie
    Dhir, Rajiv
    Wells, Alan
    CANCER MICROENVIRONMENT, 2012, 5 (01) : 19 - 28
  • [28] Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases
    Chao, Yvonne
    Wu, Qian
    Acquafondata, Marie
    Dhir, Rajiv
    Wells, Alan
    CANCER RESEARCH, 2011, 71
  • [29] Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
    N. P. A. Devika Gunasinghe
    Alan Wells
    Erik W. Thompson
    Honor J. Hugo
    Cancer and Metastasis Reviews, 2012, 31 : 469 - 478
  • [30] Epithelial mesenchymal transition traits in human breast cancer cell lines
    Blick, T.
    Widodo, E.
    Hugo, H.
    Waltham, M.
    Lenburg, M. E.
    Neve, R. M.
    Thompson, E. W.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (06) : 629 - 642